Related Experiment Videos
Borderline--tuberculoid leprosy: clinical and immunological heterogeneity
M I Pimentel1, E P Sampaio, J A Nery
1Leprosy Laboratory, Oswaldo Cruz Institute, FIOCRUZ, Avenida Brasil, Rio de Janeiro, Brasil.
Leprosy Review
|December 1, 1996
Summary
Leprosy patients show varied immune responses. Interferon gamma (IFN-γ) may limit skin spread but potentially worsen nerve involvement in borderline tuberculoid leprosy.
Area of Science:
- Immunology
- Dermatology
- Infectious Diseases
Background:
- Borderline tuberculoid leprosy presents with diverse skin and nerve involvement.
- Understanding the immunological underpinnings is crucial for effective management.
Purpose of the Study:
- To analyze immunological criteria in borderline tuberculoid leprosy patients.
- To correlate immune responses with clinical manifestations like skin lesions and nerve damage.
Main Methods:
- Assessed lepromin reaction, lymphoproliferation test (LTT) to Mycobacterium leprae antigens, and IFN-γ levels.
- Measured anti-PGL-1 antibodies in patient sera.
- Correlated immunological findings with clinical presentation (skin/nerve involvement).
Main Results:
- 39.6% had positive lepromin reactions; positive tests correlated with more skin lesions.
- 57% showed positive LTT; unresponsiveness linked to less nerve involvement.
- 22% released high IFN-γ levels; these patients had fewer skin lesions but often nerve damage.
- 90.5% lacked anti-PGL-1 antibodies, confirming a tuberculoid profile.
Conclusions:
- IFN-γ may restrict leprosy spread in skin but could exacerbate nerve damage.
- Immune responses, particularly IFN-γ, play a complex role in leprosy pathogenesis.
- Findings suggest potential therapeutic targets related to cytokine modulation.